Publication | Closed Access

Intravitreal Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: The Second Year of a Prospective Study

Ocular DiseaseVitreous BodyOphthalmologyAge-related DiseasesSecond YearGlaucomaProspective StudyMedicineIntravitreal Bevacizumab